On the Bank Nifty, still Bank Nifty is struggling to give a decisive breakout above 50,000 mark, so that is the challenging level at this moment based on the call concentration.
UBS sells shares worth Rs 480 crore in Concord Biotech, IIFL Securities, 2 more stocks via block deals
UBS sold holdings in Concord Biotech, Five Star Business Finance, IIFL Securities, and Marksans Pharma through block deals, totaling Rs 480 crore. The largest sale